Bundang Rehabilitative Impact Study of the Elbow Epicondylitis
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This study is to assess the safety and effect of polydeoxyribonucleotide(PDRN) on the lateral
epicondylitis with ultrasonography-guided injection of the PDRN or dextrose solution.
Condition: lateral epicondylitis
Intervention Drug: polydeoxyribonucleotide, PDRN Drug: dextrose solution, 15% as
prolotherapy, active control
Phase 4
Study type: Interventional
Study design: Treatment, Parallel Assignment, Double Blind((Subject, intervention performer,
Investigator, Outcomes Assessor), Randomized, Safety/Efficacy Study
Official Title: Safety and Effects of PDRN(polydeoxyribonucleotide) Injection in Patient with
elbow epicondylitis in randomized double-blind active-control comparative study
Estimated Enrollment: 40